No Data
No Data
Leerink Partners Maintains GoodRx(GDRX.US) With Buy Rating, Maintains Target Price $10
GoodRx Holdings: Undervalued Stock With Strong EBITDA Growth and Positive Outlook
GoodRx Helps Announces Recipients of 2024 Students for Healthcare Equity Scholarship
Harrow Stock Plunges 20% on Weaker-than-expected Q3 Earnings
Citi Maintains GoodRx(GDRX.US) With Buy Rating, Cuts Target Price to $7
RBC Capital Maintains GoodRx(GDRX.US) With Buy Rating, Maintains Target Price $8.5
Tan Chin Seng klang : must buy more apples and Nvidia